Insights+: COVID-19 Healthcare News Monthly Updates – May 2020

 Insights+: COVID-19 Healthcare News Monthly Updates – May 2020

Our planet is facing a major pandemic outbreak due to COVID-19 and health agencies are taking every measure to stop it. The COVID-19 virus has been named “SARS-CoV-2” (severe acute respiratory syndrome coronavirus 2) and the disease it causes has been named “Coronavirus Disease 2019” (COVID-19). The outbreak of the respiratory disease was first detected in Wuhan City, Hubei Province, China in Dec 2019. Life sciences companies are putting all of their efforts into finding a treatment or developing a vaccine for this disease. PharmaShots is keeping a track of all of the important updates in the Lifesciences sector, where we have covered news updates regarding collaborations, clinical trials, funding, and regulatory guidelines related to the COVID-19 from Jan to date. 

231. Early Data Show Cancer Progression Associated with Increased Risk of Death in Patients With COVID-19

May 28, 2020 | Clinical Trial

230. The Global Impact of COVID-19 on People with Cancer

May 28, 2020 | Regulatory

229. Chimeron Bio and George Mason University’s National Center for Biodefense and Infectious Diseases Collaborate to Develop COVID-19 Vaccine using ChaESAR Technology

May 28, 2020 | Collaboration

228. Oxford Biomedica Signs Clinical & Commercial Supply Agreement with AstraZeneca for Manufacture of COVID-19 Vaccine Candidate

May 28, 2020 | Clinical Trial

227. IRBM’s Advent Announces Manufacture of 13,000 Doses of Covid-19 Vaccine, for Use in P-II/III Study by the University of Oxford

May 28, 2020 | Clinical Trial

226. ARCA Reports AB201 Development Program for Treatment of COVID-19 Associated Coagulopathy

May 28, 2020 | Collaboration

225. Cordenpharma & Moderna Extend Strategic Manufacturing Services Agreement for Supplying Lipid Excipients To Be Used In mRNA-1273 Against The Novel Coronavirus Sars-Cov-2

May 28, 2020 | Collaboration

224. Cerecor Reports FDA Clearance of IND for CERC-002 in COVID-19 Induced ARDS

May 28, 2020 | Clinical Trial

223. PureTech Advances LYT-100 (Deupirfenidone) for Treatment of Serious Respiratory Complications that Persist Following Resolution of COVID-19 Infection

May 28, 2020 | Clinical Trial

222. Orpheris to Initiate Phase 2 Study Evaluating OP-101 in Severe COVID-19 Patients

May 28, 2020 | Clinical Trial

221. EU Launches New COVID-19 Fundraising to Address Concerns Over Equal Access

May 28, 2020 | Regulatory

220. SAB Biotherapeutics Confirms Neutralizing Antibodies to SARS-CoV-2 and Begins Clinical Manufacturing of Novel COVID-19 Therapeutic Candidate

May 28, 2020 | Clinical Trial

219. Octapharma USA & BioMatrix Support Research Focused on COVID-19 & Myocardial Dysfunction

May 28, 2020 | Collaboration

218. Oncopeptides Reinitiates Patient Enrollment to the Melflufen Clinical Program Following a Temporary Pause Due to the COVID-19 Pandemic

May 28, 2020 | Clinical Trial

217. Atossa Therapeutics Reports Second COVID-19 Therapeutic Development Program, AT-301 Nasal Spray

May 28, 2020 | Clinical Trial

216. Synairgen Completes Recruitment of Hospitalised Patients in COVID-19 Trial

May 28, 2020 | Clinical Trial

215. CalciMedica Reports Positive Interim Analysis of Trial Evaluating Auxora in Patients with Severe COVID-19 Pneumonia

May 28, 2020 | Clinical Trial

214. European Medicines Regulatory Network Fully Mobilised In Fight Against COVID-19

May 28, 2020 | Regulatory

213. Apellis Initiates P-I/II Study of APL-9 in Patients with Severe COVID-19

May 28, 2020 | Clinical Trial

212. resTORbio Initiates Study Evaluating RTB101 for Reducing the Severity of COVID-19 in Nursing Home Residents

May 28, 2020 | Clinical Trial

211. FDA Provides New Tool to Aid Development and Evaluation of Diagnostic Tests That Detect SARS-CoV-2 Infection

May 28, 2020 | Diagnostic

210. African and Global Philanthropists Collaborate to Manufacture COVID-19 Medical Equipment in Africa

May 28, 2020 | Collaboration

209. Siemens Healthineers Now Shipping Worldwide Total Antibody Test and Molecular Test Kit for COVID-19 with Expanded Capacity

May 28, 2020 | Diagnostic

208. GenScript Receives CE Marking for Its Neutralizing Antibody Test Kit of SARS-CoV-2 and COVID-19 Diagnostic Products

May 28, 2020 | Diagnostic

207. Philips Launches Next Generation Wearable Biosensor for Early Patient Deterioration Detection, Including Clinical Surveillance for Covid-19

May 28, 2020 | DigiHealth

206. FDA Provides Promised Transparency for Antibody Tests

May 28, 2020 | Regulatory

205. Abbott Reports Clinical Study Data on ID Now COVID-19 Rapid Test Showing Strong Agreement to Lab-Based Molecular PCR Tests

May 28, 2020 | Diagnostic

204.  Novartis Signs a Manufacturing Agreement with Massachusetts Eye and Ear and Massachusetts General Hospital for AAVCOVID Vaccine Program

May 28, 2020 | Collaboration

203. Roche Initiates P-III REMDACTA Study Evaluating Actemra (tocilizumab) + Remdesivir for Hospitalized Patients with Severe COVID-19 Pneumonia

May 28, 2020 | Clinical Trial

202. Atriva to Initiate P-II Clinical Study Evaluating ATR-002 for Treatment of Patients with COVID-19

May 28, 2020 | Clinical Trial

201. Organicell Reports Positive Results from Compassionate Use of Organicell Flow in Severely Ill COVID-19 Patients

May 27, 2020 | Clinical Trial

200.  Ajinomoto Bio-Pharma Signs Manufacturing Agreement with Humanigen for Lenzilumab, Currently in FDA-Approved Phase III Study for COVID-19

May 27, 2020 | Collaboration

199. Hackensack Meridian Health Finds First Treatment (tocilizumab) to Improve Survival in COVID-19 Patients

May 27, 2020 | Clinical Trial

198. I-Mab Reports Interim Results from Part 1 Study for Anti-GM-CSF Antibody TJM2 to Treat COVID-19 Patients with Cytokine Release Syndrome

May 27, 2020 | Clinical Trial

197. Health Canada to Accelerate Access to Health Products for COVID-19

May 27, 2020 | Regulatory

196. Anivive Repurposes GC376 for COVID-19 And Submits Pre-IND to FDA

May 27, 2020 | Regulatory

195. Heat Biologics Announces Collaboration with Waisman Biomanufacturing to Manufacture COVID-19 Vaccine

May 27, 2020 | Collaboration

194. Virna Therapeutics and University of Toronto Announce Licensing of Neutralizing Monoclonal Antibodies to Treat COVID-19

May 27, 2020 | Collaboration

193. ImmunityBio & NantKwest Signs an Agreement for Vaccine Against COVID-19

May 27, 2020 | Collaboration

192. MilliporeSigma and Baylor College of Medicine Collaborate to Advance a Vaccine Manufacturing Platform to Fight Covid-19

May 27, 2020 | Collaboration

191. PhaseBio Launches Clinical Trial to Evaluate PB1046 as a Treatment for Hospitalized COVID-19 Patients

May 27, 2020 | Clinical Trial

190. Moleculin Provides Update on Drug Development for COVID-19

May 27, 2020 | Clinical Trial

189. Aerpio and Quantum Leap Collaborative Announce the Selection of Razuprotafib for Evaluation in the I-SPY COVID Trial to Treat ARDS in COVID-19 Patients

May 27, 2020 | Clinical Trial

188. Glenmark to Initiate P-III Clinical Study Evaluating the Combination Therapy for Hospitalized Patients with COVID-19 in India

May 26, 2020 | Clinical Trial

187. Racing Against Time, Medical Researchers, Life Science Companies and COVID-19 Survivors Launch National Campaign to Drive Blood Plasma Donation

May 26, 2020 | Grant

186. Japan’s MHLW to Approve Avigan for COVID-19 by End of May

May 26, 2020 | Regulatory

185. Apotex Donates Critical Medicines to Combat COVID-19

May 26, 2020 | Grant

184. Selected NHS Patients to Access Remdesivir

May 26, 2020 | Clinical Trial

183. Innovation Receives Data from Public Health Research Institute Showing Brilacidin Inhibits SARS-CoV-2 Infection in a Human Cell Line

May 26, 2020 | Clinical Trial

182. Synairgen Provides Update on Expanded SG016 Trial for Patients with COVID-19

May 26, 2020 | Clinical Trial

181. Eli Lilly and Junshi to Initiate Clinical Trials of COVID-19 Antibody in Q2’2020

May 26, 2020 | Clinical Trial

180. Bayer to Support Harvard Research Study to Evaluate Trust in Science in COVID-19 Pandemic

May 26, 2020 | Collaboration

179. Ceapro Expands its Research Program with McMaster University to Develop Inhalable Therapeutic for COVID-19

May 26, 2020 | Collaboration

178. EMA calls for High-Quality Observational Research in Context of COVID-19

May 26, 2020 | Regulatory

177. Montefiore and Einstein Test a New Drug Combination to Conquer COVID-19

May 26, 2020 | Clinical Trial

176.  Diffusion Pharmaceuticals Receives Accelerated FDA Response to Proposed TSC COVID-19 Clinical Trial Program

May 26, 2020 | Clinical Trial

175. Algernon Reports Submission of IND to the US FDA for Ifenprodil to Treat COVID-19

May 26, 2020 | Regulatory

174. Co-Diagnostics’COVID-19 Test Successfully Used to Identify Coronavirus in Cancer Tissue

May 26, 2020 | Diagnostic

173. Merck to Acquire Themis

May 26, 2020 | Collaboration

172. IAVI and Merck Collaborate to Develop Vaccine Against SARS-CoV-2

May 26, 2020 | Collaboration

171. Merck and Ridgeback Bio Collaborate to Advance Development of Novel Antiviral Candidate EIDD-2801 Against COVID-19

May 26, 2020 | Collaboration

170. Japan’s AnGes Focuses to Release COVID-19 Vaccine By The End of Year

May 25, 2020 | Clinical Trial

169. Philippines To Take Part in 2 Taiwanese Clinical Trials for COVID-19

May 25, 2020 | Clinical Trial

168. AstraZeneca to Begin Supplying 100M Doses of COVID-19 Vaccine to UK from September

May 25, 2020 | Clinical Trial

167. WHO Pauses Trial of Hydroxychloroquine in COVID-19 Patients Due to Safety Concerns

May 25, 2020 | Regulatory

166. BARDA Funds $1B to AstraZeneca for Research and Development of Novel COVID-19 Vaccine

May 22, 2020 | Grant

165. Color Receives FDA Emergency Use Authorization for COVID-19 Test Using Isothermal Amplification

May 21, 2020 | Diagnostic

164. Vayyar Collaborate with Meditemi to Detect Early Stage COVID-19 Symptoms in Under 10 Seconds

May 21, 2020 | Collaboration

163. Pathnostics Launches COVID-19 PCR Laboratory Test Designed to Detect Acute Infection

May 21, 2020 | Launch

162. Abbott Releases Interim Clinical Study Data On ID Now COVID-19 Rapid Test Showing Strong Agreement To Lab-Based Molecular PCR Tests

May 21, 2020 | Diagnostic

161.  Britain Signs Agreement with Roche and Abbott for 10M Antibody Tests

May 21, 2020 | Diagnostic

160. AbbVie Reports 26 Nonprofits Selected for the COVID-19 Community Resilience Fund

May 21, 2020 | Grant

159.  ADMA Biologics Commences Collection of COVID-19 Plasma from Recovered Patients

May 21, 2020 | Clinical Trial

158.  CalciMedica Reports that FDA Has Strongly Recommended Moving to a Blinded Placebo-controlled Trial with Auxora in Patients with Severe COVID-19 Pneumonia

May 21, 2020 | Clinical Trial

157.  FibroGenesis Reports COVID-19 Breakthrough Using Fibroblast Cell Therapy (Pre-Clinical Trial Phase)

May 21, 2020 | Clinical Trial

156. Amarin Supports Study to Investigate the Effects of Vascepa (Icosapent Ethyl) in The Treatment Of COVID-19

May 21, 2020 | Clinical Trial

155. IMV Announces Selection of a Vaccine Candidate Against COVID-19 to Advance into Human Clinical Studies

May 21, 2020 | Clinical Trial

154. Montefiore-Einstein Scientists Lead Two Trials of Leronlimab Against COVID-19

May 21, 2020 | Collaborations

153.  Kleo Pharmaceuticals and Celularity Collaborate to Rapidly Develop Allogeneic NK Cell Combination Therapies for COVID-19 and Multiple Myeloma

May 21, 2020 | Collaborations

152. Atomwise Partners with Global Research Teams to Pursue Broad-Spectrum Treatments Against COVID-19 and Future Coronavirus Outbreaks

May 21, 2020 | Collaboration

151. Takara Bio Selects AGC Biologics as Manufacturer of Plasmid DNA Intermediate for a Vaccine Against COVID-19

May 21, 2020 | Collaboration

150. AstraZeneca Receives First Supply Agreement for University of Oxford’s ChAdOx1 nCoV-19 Vaccine Against COVID-19

May 21, 2020 | Collaboration

149.  Health Canada Clears Appili Therapeutics’ P-II Clinical Trial Evaluating Favipiravir as a Prophylactic Agent Against COVID-19 Outbreaks

May 21, 2020 | Clinical Trial

148. Indica Labs, Octo, and Axle Work with NIH to Launch a Global COVID-19 Digital Pathology Repository

May 21, 2020 | Launch

148. Apple and Google Launch COVID-19 Exposure Notification System to Support Health Agencies

May 20, 2020 | DigiHealth

147.  IMV Reports Selection of a Vaccine Candidate Against COVID-19 to Advance Into Human Clinical Studies

May 20, 2020 | Clinical Trial

146. Bio-Techne and Kantaro Biosciences Collaborate to Develop And Scale Production of COVID-19 Serology Test

May 20, 2020 | Collaboration

145. Vaxart Reports Selection of its Oral COVID-19 Vaccine Lead Candidate

May 20, 2020 | Clinical Trial

144.  Rising Pharmaceuticals to Support P-II Study of Chloroquine Phosphate for Prophylaxis Against COVID-19 in Healthcare Workers at Risk for COVID-19

May 20, 2020 | Clinical Trial

143. Atossa Therapeutics Reports In vitro Testing Results of COVID-19 Drug

May 20, 2020 | Clinical Trial

142.  CanSino Biologics and Precision NanoSystems  Collaborate to Co-Develop a COVID-19 RNA Vaccine

May 20, 2020 | Collaboration

141. Airway Therapeutics and Celonic Group Collaborate to Produce AT-100 as Promising Candidate for COVID-19

May 20, 2020 | Collaboration

140. Hoth Therapeutics Licenses Novel Peptide COVID-19 Therapeutic

May 20, 2020 | Collaboration

139.  Atea Pharmaceuticals Reports IND Clearance of AT-527 for COVID-19 and $215M Funding

May 20, 2020 | Regulatory and Grant

138. FDA Approves Octapharma’s IND for Severe COVID-19 Patients

May 20, 2020 | Regulatory

137.  KANCERA Initiates P-II Study of KAND567 in COVID-19 Patients

May 20, 2020 | Clinical Trial

136.  INOVIO’s INO-4800 Demonstrates Robust Neutralizing Antibody and T Cell Immune Responses in Preclinical Models

May 20, 2020 | Clinical Trial

135.  Aldeyra Therapeutics to Advance ADX-1612 to Clinical Testing and Provides Update on ADX-629 for COVID-19

May 20, 2020 | Clinical Trial

134. Roche Launches Elecsys Anti-SARS-CoV-2 Antibody Blood Test in the US

May 20, 2020 | Launch

133.  Bharat Biotech and Thomas Jefferson University Pursue a Promising Vaccine Candidate Against COVID-19

May 20, 2020 | Collaboration

132. Avacta and Medusa19 Signs a Distribution Agreement For COVID-19 Antigen Test

May 20, 2020 | Collaboration

131. AstraZeneca is in Discussion with Other Governments to Replicate UK Vaccine Deal

May 19, 2020 | Collaboration

130. Covis Initiates P-III Clinical Trial of Alvesco (ciclesonide) Inhaler for the Treatment of COVID-19

May 19, 2020 | Clinical Trial

129.  Sandoz Responds to Increased Demand for Antibiotics and Other Essential Medicines for Patients Amid COVID-19

May 19, 2020 | Pharma

128.   XORTX Provides Update Regarding XRx-008 for ADPKD and XRx-101 for COVID-19 Programs

May 19, 2020 | Clinical Trial

127.  St. Elizabeth Healthcare Partners with CTI and Pulmotect Becoming First Hospital Site for Phase-2 Clinical Trial Targeting COVID-19

May 19, 2020 | Collaboration

126.  Natco Donates Chloroquine for International Study to Prevent COVID-19

May 19, 2020 | Grant

125. Be The Match BioTherapies and NantKwest Collaborate to Accelerate Development of Cell Therapy to Prevent COVID-19 Deaths

May 19, 2020 | Collaboration

124.  NIH-funded Study to Investigate Pregnancy Outcomes Resulting from COVID-19 Pandemic

May 19, 2020 | Grant

123. FDA Collaborations Promote Rigorous Analyses of Real-World Data to Inform Pandemic Response

May 19, 2020 | Regulatory

122. Arch Biopartners Expands the Primary Endpoint of its Phase II Trial to Include Prevention of Multiple Organ Injuries in Patients with COVID-19

May 19, 2020 | Clinical Trial

121.  Adjuvance Technologies Reports NIH Funding for COVID-19 Vaccine Research

May 19, 2020 | Grant

120.  Oragenics and Aragen Bioscience Enter into an Agreement to Accelerate Development of TerraCoV2 Against COVID-19

May 18, 2020 | Diagnostic

119. GeneME Develops On-Premise FRANKD Mouth Swab Test for COVID-19

May 18, 2020 | Diagnostic

118. Quidel’s Lyra Direct Sars-Cov-2 Assay Receives Emergency Use Authorization and CE Mark For Molecular Detection Of Covid-19, Without Extraction Step

May 18, 2020 | Diagnostic

117.  GC Pharma to Provide Covid-19 Treatment for Free

May 18, 2020 | Grant

116. NantKwest Reports FDA Authorization of IND Application for Mesenchymal Stem Cell Product for the Treatment of Severe COVID-19

May 18, 2020 | Regulatory

115.  Bonus BioGroup Reports Successful Treatment of Acute Pneumonia in Preclinical COVID-19 Model

May 18, 2020 | Clinical Trial

114.  Global Regulators Work Towards Alignment on Policy Approaches and Regulatory Flexibility During COVID-19

May 18, 2020 | Regulatory

113. EMA to Grant Initial Authorization to Gilead’s Remdesivir for COVID-19 in Coming Days

May 18, 2020 | Regulatory

112. Moderna Reports Positive Interim P-I Data of mRNA-1273 Against COVID-19

May 18, 2020 | Clinical Trial

111. Health Canada Approves First Clinical Trial for Potential COVID-19 Vaccine

May 17, 2020 | Regulatory

110.  UK’s Government to Invest £84M for Boosting COVID-19 Vaccine Program

May 17, 2020 | Grant

109. Leading BioSciences Receives IND Clearance for Phase 2 COVID-19 Study

May 15, 2020 | Regulatory

108. Can-Fite Announces Pre-IND Submission to US FDA for Piclidenoson in the Treatment of COVID-19 Infected Patients with Moderate-to-Severe Symptoms

May 15, 2020 | Regulatory

107. Tech Mahindra Leverages AI for Potential COVID-19 Therapeutic Drugs

May 15, 2020 | DigiHealth

105. Algernon Reports Submittion for Ethics Approval of its P-IIb/III Human Study of Ifenprodil for COVID-19

May 15, 2020 | Regulatory

104. Mirror Biologics and Immunovative Therapies Announce Publication 0f The Technical Rationale for Development of A Universal Anti-Viral Vaccine Targeted To Protect Adults From COVID-19

May 15, 2020 | Collaboration

103. Avacta Develops SARS-COV-2 Neutralising Affimer Reagents for COVID-19

May 15, 2020 | Diagnostic

102. ImmuPharma Porvides Updates on its Activities Against Covid-19 with Lupuzor and Ureka

May 14, 2020 | Clinical Trial

101. Kaleido Initiates Controlled Clinical Study of KB109 in Outpatients with Mild-to-Moderate COVID-19

May 14, 2020 | Clinical Trial

100.  Relief Therapeutics and NeuroRx Report Final Manufacturing Validation of RLF-100 for P-IIb/III Clinical Study in Patients with COVID-19 Associated Acute Respiratory Distress Syndrome

May 14, 2020 | Clinical Trial

98. AIM ImmunoTech Report the US FDA Authorization for First Human Ampligen Study in COVID-19 Patients with Cancer

May 14, 2020 | Regulatory

97. NIH Initiates Clinical Trial of Hydroxychloroquine and Azithromycin to Treat COVID-19

May 14, 2020 | Clinical Trial

96. Enzychem Initiates P-II Study for EC-18 in Preventing ARDS Due to Coronavirus Pneumonia

May 14, 2020 | Clinical Trial

95. Abivax Receives ANSM and Ethics Committee clearance to Evaluate ABX464 in P-IIb/III Study for COVID-19

May 14, 2020 | Clinical Trial

94. Danish Team of Researchers to Test Treatment of Critically Ill Patients Suffering from COVID-19

May 14, 2020 | Clinical Trial

93. Sanofi’s COVID-19 Vaccine to be Available Globally

May 14, 2020 | Clinical Trial

92. Gilead Donates Remdesivir to Japan

May 14, 2020 | Grant

91.  Health Groups Ask India To Rescind Gilead’s Patents For Remdesivir

May 14, 2020 | Regulatory

90. Immunic Receives German Health Authority’s Approval to Initiate a P-II Clinical Trial of itsv IMU-838 in COVID-19 Patients

May 13, 2020 | Regulatory

89. Purdue-Developed Nanomaterial Significantly Enhances Potential COVID-19 Therapeutic

May 13, 2020 | Clinical Trial

88. Roivant Provides Updates for Pivotal BREATHE Study Evaluating Gimsilumab in COVID-19 Patients for the Prevention of Acute Respiratory Distress Syndrome

May 13, 2020 | Clinical Trial

87. Fluxergy Announces $30M to Expand Manufacturing Capacity of Its One-hour POC Diagnostic Testing System in Response to COVID-19

May 13, 2020 | Grant

86. NEOVII Collaborates with Tel Aviv University to Develop Novel COVID-19 Vaccine

May 13, 2020 | Collaboration

85.  FDA Permits Use of Aidoc’s AI Algorithms to Detect and Prioritize Incidental CT Findings Associated With COVID-19

May 12, 2020 | Regulatory

84. Vitagene Launches the First FDA Authorized Saliva Based “Zero Contact” COVID-19 At Home Test

May 12, 2020 | Diagnostics

83. Quidel’s Sofia 2 SARS Antigen FIA Receives the US FDA’s EUA as the First Antigen Test for Rapid Detection of COVID-19

May 12, 2020 | Diagnostics

82. MedTek21 and AccessDx  Reports the Availability of COVID-19 Testing Solution

May 12, 2020 | Diagnostics

81. Glenmark Initiates P-III Clinical Study of Favipiravir for COVID-19 Patients in India

May 12, 2020 | Clinical trial

80. FDA Takes New Actions to Accelerate Development of Novel Treatment Options for COVID-19

May 12, 2020 | Regulatory

79. Nascent Biotech and Manhattan BioSolutions Collaborate to Advance Vaccine Discovery and Development for COVID-19

May 12, 2020 | Collaboration

78. COVID-19 Therapeutics Accelerator Grants $3M to MHI Research Institute for its ColCorona COVID-19 Clinical Trial

May 12, 2020 | Grant

77. GreenLight to Raises $17M to Accelerate Large-Scale Manufacturing of COVID-19 vaccines

May 12, 2020 | Grant

76.  Veru to Initiate P-II Study of VERU-111 to Combat COVID-19

May 12, 2020 | Clinical Trial

75. Moderna’s mRNA-1273 Receives the US FDA’s Fast Track Designation to Treat COVID-19

May 12, 2020 | Regulatory

74.  Gilead Collaborates with Generics Makers to Supply Remdesivir in 127 Countries

May 12, 2020 | Collaboration

73. GRYT Health and Bristol Myers Squibb Team Up to Launch COVID Advocacy Exchange for Patient Advocates

May 12, 2020 | Collaboration

72. FDA Expedites Clearance of Caption Health Ultrasound Software to Aid Frontline Healthcare Workers in Fight Against COVID-19 Pandemic

May 12, 2020 | Regulatory

71. The National Research Council of Canada and CanSino Biologics Inc. announce collaboration to advance vaccine against COVID-19

May 12, 2020 | Collaboration

70. COVID-19 Patients Cared for Using EarlySense’s Contact-free Continuous Monitoring Solution at Leading Hospital in the Netherlands

May 12, 2020 | Diagnostics

74. Themis collaborates with ABL Europe to manufacture its SARS-CoV-2 Vaccine Candidate in France

May 11, 2020 | Collaboration

69. Glenmark introduces 3-in-1 inhaler therapy for COPD in India, promising reduction in risk of severe attacks and improvement in lung function

May 11, 2020 | Diagnostics

68. Abbott Receives FDA Emergency Use Authorization for COVID-19 Antibody Blood Test on Alinity™ i System

May 11, 2020 | Diagnostics

67.Themis collaborates with ABL Europe to manufacture its SARS-CoV-2 Vaccine Candidate in France

May 11, 2020 | Collaboration

66.  KC Wearable Announces Major Partnerships with European Authorities to Combat COVID-19

May 11, 2020 | Collaboration

65. Kiniksa Reports Data for Mavrilimumab in COVID-19 Pneumonia and Hyperinflammation and for Vixarelimab in Diseases Characterized by Chronic Pruritus

May 11, 2020 | Clinical Trial

64. Sorrento Collaborates with Mount Sinai Health System to Develop COVI-SHIELD Antibody Cocktail Targeting COVID-19 

May 08, 2020 | Collaboration

63. GSK to Evaluate Otilimab for Treating Pulmonary Disease Associated with COVID-19

May 07, 2020 | Clinical Trial

62. CoVIg-19 Plasma Alliance to Initiate Clinical Study Evaluating Hyperimmune Therapy for COVID-19 by Summer 2020

May 07, 2020 | Collaboration

61. Gilead’s Veklury (remdesivir) Receives MHLW’s Approval for Patients with Severe COVID-19 in Japan

May 07, 2020 | Regulatory

60. Moderna Anticipates the Initiation of P-III Study of mRNA-1273 for COVID-19 by Early Summer

May 07, 2020 | Clinical Trial

59. Tonix Pharmaceuticals Collaborates with the University of Alberta to Develop Novel Horsepox-Based Vaccines for the Prevention of COVID-19

May 07, 2020 | Collaboration

58. Enlivex Reports Initiation of P-II Clinical Trial of Allocetra in COVID-19 Patients

May 07, 2020 | Clinical Trial

57. NIH-Sponsored COVID-19 Clinical Trial Begins at The Lundquist Institute

May 07, 2020 | Clinical Trial

56. PARI’s Nebulizer Used in the Study with Pulmotect’s Inhaled PUL-042 for COVID-19

May 07, 2020 | Clinical Trial

55. FDA Continues to Combat Fraudulent COVID-19 Medical Products

May 07, 2020 | Regulatory

54. Vanderbilt University Collaborates with IDBiologics to Develop Breakthrough Medicines for COVID-19

May 07, 2020 | Collaboration

53. Fraunhofer Research Consortium iCAIR Uses Synergies to Develop therapies Against COVID-19

May 07, 2020 | Collaboration

52. Euroimmun’s Serology Test Receives the US FDA’s EUA To Identify COVID-19 Antibodies

May 07, 2020 | Diagnostic

51. Polar Pak to manufacture face shields for Health Canada to Combat COIVD-19

May 06, 2020 | Pharma

50. AB Science Initiates P-II Study Evaluating Masitinib In Combination with Isoquercetin For The Treatment of COVID-19

May 06, 2020 | Clinical Trial

49. Humanigen Reports First Patients Dosing in Phase III Study with Lenzilumab with COVID-19

May 06, 2020 | Clinical Trial

48. Adimmune’s Vaccine Requires Further Testing to Initiate Clinical Testing for COVID-19

May 06, 2020 | Clinical Trial

47. CSL Behring Initiates the Development of Plasma Treatment from Recovered COVID-19 Patients

May 06, 2020 | Clinical Trial

46. Relief Therapeutics’ Aviptadil Enters FDA Trial to Treat COVID-19-Induced Acute Respiratory Distress

May 06, 2020 | Clinical Trial

45. Laurent Receives Health Canada’s Approval to Initiate Clinical Study Evaluating LAU-7b for COVID-19

May 06, 2020 | Regulatory

44. Mesoblast Reports First Patient Dosing in P-II/III Study with Remestemcel-l for COVID-19 Acute Respiratory Distress Syndrome

May 06, 2020 | Clinical Trial

43. Gilead Sciences to Expand Global Supply of Remdesivir

May 06, 2020 | Clinical Trial

42. Bavarian Nordic Collaborates with AdaptVac to Advance COVID-19 Vaccine Program

May 06, 2020 | Collaboration

41. Regeneron Anticipates the Initiation of Clinical Study for its COVID-19 Antibody Cocktail in June

May 05, 2020 | Clinical Trial

40. CohBar To Target COVID-19 Associated ARDS with its Apelin Receptor Agonist Peptides

May 05, 2020 | Clinical Trial

39. Athersys Commences Patient Enrollment in P-II/III MACOVIA Study Evaluating MultiStem Cell Therapy for COVID-19 Induced ARDS

May 05, 2020 | Clinical Trial

38. Innovation to Evaluate the Inhibitory Effect of Brilacidin In Patients with COVID-19

May 05, 2020 | Clinical Trial

37. The Israel Institute for Biological Research Completes the Development Phase of COVID-19 Antibody

May 05, 2020 | Clinical Trial

36. NIH to Fund COLCORONA Clinical Study for COVID-19

May 05, 2020 | Grant

35. Diffusion Pharmaceuticals Reports FDA’s  Accelerated Review of TSC Clinical Development Plan to Treat COVID-19 Patients with ARDS

May 05, 2020 | Regulatory

34. CEPI Expands COVID-19 Vaccine Portfolio Focusing on Speed And Global Manufacturing

May 05, 2020 | Grant

33. Pfizer and BioNTech Report First Patient Dosing with BNT162 in P-I/II Study for COVID-19 in the US

May 05, 2020 | Clinical Trial

32. Bio-Rad Receives the US FDA’s Emergency Use Authorization for its Droplet Digital PCR Test Kit to Detect COVID-19

May 05, 2020 | Diagnostic

31. Bocconi University’s New Research Laboratory on COVID-19

May 05, 2020 | Pharma

30. EMA Fast-Tracks Development and Approval Of Medicines And Vaccines for COVID-19

May 04, 2020 | Regulatory

29. Arcturus Therapeutics and Catalent Collaborate to Manufacture mRNA-Based COVID-19 Vaccine

May 04, 2020 | Collaboration

28. NanoViricides Signs Confidential Disclosure Agreement with International Pharmaceutical Company to Explore Collaborating on its COVID-19 Program

May 04, 2020 | Collaboration

27. Generex Biotechnology Initiates Peptide Manufacturing for Ii-Key- SARS-CoV-2 Peptide Vaccine Against the COVID-19

May 04, 2020 | Clinical Trial

26. FDA Approves 54 Emergency INDs for Leronlimab to Treat COVID-19

May 04, 2020 | Regulatory

25. Utrecht University, Erasmus Medical Center and Harbour BioMed Researchers Report Discovery of Ab Targeting COVID-19

May 04, 2020 | Collaboration

24. CARE to Conduct Clinical Studies For Primary & Secondary Prophylaxis to Reduce COVID-19 Hospitalizations

May 04, 2020 | Clinical Trial

23. Applied DNA and Takis Biotech Produces Neutralizing Antibodies Against SARS-CoV-2 Following DNA Vaccination in Animals

May 04, 2020 | Clinical Trial

22. Vir and Alnylam Anticipate the Initiation of Clinical Study Assessing VIR-2703 By the Year End

May 04, 2020 | Clinical Trial

21. Lilly and Junshi Collaborate to Co-Develop Antibody Therapies for the Treatment of COVID-19

May 04, 2020 | Collaboration

20. Co-Diagnostics Reports Government Approvals and Increased Orders for COVID-19 Test Kits

May 04, 2020 | Diagnostic

19. Aridis Enrolls its First COVID-19 Patient in Ongoing P-III AR-301 Study in Ventilator Associated Pneumonia

May 04, 2020 | Clinical Trial

18. MHLW Expedites the Reviews of Gilead’s Remdesivir to Treat Patients with COVID-19 in Japan

May 03, 2020 | Regulatory

17. Roche Receives FDA’s Emergency Use Authorization for its Elecsys to Detect COVID-19

May 03, 2020 | Diagnostic

16. Bravado Health Collaborates with K-Rain to Screen Employees for COVID-19

May 01, 2020 | Collaboration

15. NASA’s Ventilators Receives the UD FDA’s Emergency Use Authorization  

May 01, 2020 | Regulatory

14. Glenmark Receives DCGI’s Approval to Evaluate Favipiravir for COVID-19 Patients in India

May 01, 2020 | Regulatory

13. Gilead’s Remdesivir Receives the US FDA’s Emergency Use Authorization for the Treatment of COVID-19

May 01, 2020 | Regulatory

12. Moderna Signs a Ten-Year Worldwide Agreement with Lonza to Manufacture mRNA-1273 Against COVID-19

May 01, 2020 | Collaboration

11. Health Canada to Assess the Role Convalescent Plasma for Treating COVID-19

May 01, 2020 | Regulatory

10. PROMETRIKA and Karyopharm Collaborated to Evaluate XPOVIO in Hospitalized Patients with Severe COVID-19.

May 01, 2020 | Clinical Trial

9. EvergreenHealth to Initiate Next Phase 0f Clinical Research Evaluating Remdesivir As a Potential Treatment For COVID-19

May 01, 2020 | Clinical Trial

8. Astellas Pharma Support Solutions Addressing Evolving Patient Needs During COVID-19

May 01, 2020 | Pharma

7. WHO says COVID-19 emergency declaration gave world “enough time”

May 01, 2020 |Regulatory

6. NICE Publishes Rapid Guidelines for COVID-19 Pandemic

May 01, 2020 |Regulatory

5. EvergreenHealth to Initiate Next Phase 0f Clinical Research Evaluating Remdesivir As a Potential Treatment For COVID-19

May 01, 2020 | Clinical Trial

4. LLNL’s Machine Learning Platform Generates Novel Covid-19 Antibody Sequences For Experimental Testing      

May 01, 2020 | DigiHealth

3. Husco-Led Consortium Develops Breakthrough Face Mask for Frontline Healthcare Professionals

May 01, 2020 | Pharma

2. Centene And Quest Diagnostics Collaborate To Increase Access To COVID-19 Testing

May 01, 2020 | Diagnostic

1. Hologic to Launch Its Second High-Throughput Molecular Assay for COVID-19

May 01, 2020 | Launch

Related Article: Insights+ Exclusive: COVID-19 Healthcare News Updates (April)

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post